In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

For years, researchers primarily focused their attention on another protein, beta-amyloid, as the cause of Alzheimer's. While ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Knight says that the method of transmission that Collinge identified is “extremely unusual,” and there’s no evidence that ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...